Gentler chemo tested for elderly cancer Patients' transplants
NCT ID NCT03352765
Summary
This early-stage study is testing a new combination of chemotherapy drugs (RBM) given before a patient's own stem cells are transplanted back into them. The goal is to see if this regimen is safer and has fewer severe side effects than the standard treatment for older adults (ages 65+) with multiple myeloma or a type of lymphoma that has returned. The study will first determine the safest dose before looking at how well it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.